Fulcrum Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.70

+0.20 (+5.71%)

As of Jun 21, 10:17 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 81%

Hold 2 13%

Sell 1 6%

Price Target

Analyst Price Target +1,440.0% upside

Low Target $37.54

Average Target $56.98

High Target $60.88

Current Price $3.70

Current
$3.70

Target
$56.98

$37.54 $56.98 avg $60.88

Scenario Analysis

Bear Case

$37.54

914.6%

Low target

Base Case

$56.98

+1,440.0%

Avg target

Bull Case

$60.88

+1,545.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$15.74

-76.5% from high

52-Week Low

$2.83

+30.7% from low

Target vs 52W High

$56.98

+262.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+19.1%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+24.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+32.1%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+41.0%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+217.3%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+168.5%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-33.2%